Little is known about blood to brain taurine transport despite substantial evidence suggesting a role of taurine in brain volume regulation during osmotic stress or conditions inducing cell swelling, such as ischemia. We have made measurements of the taurine influx rate con stant (K1) with eHltaurine in three conditions: raised plasma taurine concentrations induced by infusion with 50 mM taurine (10 l.d/IOO g/min); osmotic stress induced by i.p. injections of 1.5 M NaCI (2 millOO g) or distilled water (10 mV100 g); and 4 h of middle cerebral artery occlusion (MCAo). In rats with MCAo, additional deter minations were made of tissue water and taurine con tents, and blood-brain barrier passive permeability with [3Hlu-aminoisobutyric acid. Taurine infusion increased plasma taurine from 110 ± 63 JLM (SD) to 407 ± 63 (p < 0. 001) and decreased taurine K I at the blood-brain barrier by 70% (p < 0.001), signifying saturable uptake that main-
The sui phonic amino acid taurine is abundant in most animal tissues including brain, where it is lo cated in both glial and neuronal fractions. It has been implicated in many biological functions includ ing inhibitory neurotransmission, CNS develop ment, membrane stabilization, and blood pressure regulation (as reviewed in Wright et aI., 1986, and Huxtable, 1989) . Evidence has also accumulated from a wide range of tissues for a role of taurine in cell volume regulation, with taurine being lost from cells during hypoosmotic stress and gained during hyperosmotic stress (Huxtable, 1992 ). These changes serve to limit cell swelling and shrinkage, respectively.
Taurine appears to have a similar volume regula-tory action in brain. Taurine is lost from brain cells into the extracellular space during hypoosmotic stress (Wade et aI., 1988; Solis et aI., 1988; Leh mann, 1989 ). Furthermore, a number of pathophys iological conditions in which cerebral cells swell, such as ischemia-hypoxia, hypoglycemia, or epi lepsy, are also accompanied by pronounced in creases in extracellular taurine (Shimada et aI., 1993; Korf et aI., 1988; Tossman et aI., 1985; Wade et aI., 1987) . However, unlike in other tissues, where taurine lost to the extracellular space can diffuse into blood, the brain is separated from the blood by the blood-brain and blood-CSF barriers. Thus, if changes in brain taurine content are in volved in total brain as well as brain cell volume regulation, as is the case (Thurston et al. 1983; Tracht man et aI., 1988; Verbalis and Gullans, 1991; Sterns et aI., 1993) , transport at these barrier tissues must play an integral role. Taurine transport at the blood-brain barrier (BBB) has been investigated in isolated capillaries in vitro, revealing a sodium-dependent uptake pro-cess (Tayarani et aI., 1989 ) similar to that observed in glia and neurons (Larsson et al., 1986; Borg et al. , 1980) . Studies using isolated capillaries probably preferentially allow the examination of carrier sys tems on the brain facing rather than the blood facing side of the blood-brain barrier (Tayarani et aI., 1989; Keep et aI., 1993) and thus give information about brain to blood transport. On the other hand, little is known about taurine movement in the op posite direction, its contribution to brain taurine metabolism, or its possible role in cerebral volume regulation.
The present study examines the role of blood to brain taurine transport in brain taurine homeostasis and volume regulation by measuring the influx rate constant for eH]taurine during changes in plasma taurine concentration, osmotic stress, and middle cerebral artery occlusion (MCAo), a model of focal cerebral ischemia. Tissue taurine concentrations were also measured because the combined informa tion on influx and changes in tissue content allows assessment of efflux. A preliminary report of this work has been given (Stummer et aI., 1994) .
METHODS

General
Experiments were conducted using male Sprague Dawley rats weighing between 250 and 350 g. The animals were anesthetized with i. p. injections of pentobarbital (65 mg/kg body weight) for all procedures. Body temperature in anesthetized rats was maintained at 37-37 SC using a rectal thermometer and a feedback-controlled heating pad. Cannulas (PE50) were placed in the femoral vein for the infusion of solutions and the injection of radioisotope, and in the femoral artery for the measurement of blood pressure and blood constituents.
Three groups of experiments were performed. In the first group, the effect of elevating the concentration of plasma taurine on the influx rate constant (K,) for [3H]taurine was measured. In the second group, [3Hjtau rine influx rate constants were determined during osmotic stress. Finally, the effects of 4 h of MCAo were examined in a third group of rats. These animals were either used to measure brain taurine uptake, the uptake of [3Hja_ aminoisobutyric acid (AlB), a passive permeability marker (Blasberg et al. , 1983) , brain taurine content, or tissue water content. The AlB experiments were included to examine whether the measured changes in taurine uptake were due to an alteration in BBB passive perme ability, whereas the measurement of taurine content en abled an assessment of the taurine efflux and the impor tance of changes in taurine influx in the overall changes in brain taurine. Water content measurements were used to account for the effects of tissue swelling on these parameters.
Taurine infusion experiments
Animals received artificial plasma with or without 50 mM taurine at a volume of lOlLI/I 00 g/min i. v. for 35 min. After 30 min, an arterial blood sample was taken for the measurement of blood gases, osmolality, electrolytes, and plasma taurine. Then the taurine influx rate constant was determined with [3Hjtaurine, using ['4Cjinulin as a plasma volume marker.
Osmotic stress experiments
Animals were divided into three groups. Hypo-or hy perosmotic stress was induced by i. p. injections of 10 ml/100 g distilled water or 2 ml/100 g 1. 5 M NaCI, respec tively. Controls received 2 ml/100 g 0. 9% NaC!. After 30 min, an arterial blood sample was taken for measure ments of blood gases, plasma osmolality, and electrolyte and taurine concentrations before administration of eHjtaurine and ['4C]inulin for the determination of tau rine uptake.
MCAo experiments
MCAo was induced by the intraluminal thread occlu sion method as previously described (Longa et al. , 1990) with minor modifications. Briefly, a midline incision was made in the ventral neck region for dissection of the com mon carotid artery bifurcation, taking care not to injure the adjacent vagal nerve. After cauterization of the ptery gopalatine artery and branches of the external carotid ar tery, a 3-0 monofilament thread, rounded at the tip with a high-temperature ophthalmologic cautery device, was introduced retrogradely into the external carotid artery and advanced cranially in the internal carotid artery over a distance of exactly 19 mm, as measured from the bifur cation of the common carotid artery. The skin was then sutured and the animals were kept warm while recovering from anesthesia.
After 3. 5 h, the animals were reanesthetized and can nulas were placed in the femoral artery for blood sam pling and for the measurement of blood pressure. In those animals receiving radioisotope, an additional cannula was placed in the femoral vein. The rats were either used for the determination of cerebral tissue water content, tissue taurine content, [3Hjtaurine influx, or [3Hj-AIB influx. Experiments were terminated after 4 h by decapitation followed by rapid removal of the brains. In all animals, ischemic cortex was discernible as well-demarcated, pale tissue surrounding the MCA. The cortical mantles of both hemispheres were rapidly dissected from underlying structures and flattened on a piece of Parafilm. A cork borer with a diameter of 5 mm was used to punch a tissue sample from the center of the MCA distribution cranially to the rhinal fissure ( Fig. I ) of both hemispheres. Samples were immediately weighed and appropriately treated for the determination of tissue water content, taurine con tent, or the influx rate constants of [3Hjtaurine and eH] AlB.
Taurine influx rate constant and BBB
passive permeability
The permeability of the BBB to [3Hjtaurine and [3H] AlB was assessed by a modification of the method pro posed by Ohno et al. (1978) for a single time-point anal ysis as previously described (Betz and Coester, 1990) . For measurement of taurine uptake, a bolus of 0. 2 ml saline containing 15 ILCi eH]taurine was administered 5 min before decapitation of rats. In other animals of the MCAo group, 15 ILCi [3H]-AIB in 0. 2 ml saline was al lowed to circulate for 10 min before being killed for the determination of BBB passive permeability. After radio isotope injection, an arterial blood sample was continu- ously withdrawn at a constant rate to determine the inte gral of plasma radioactivity. For the simultaneous deter mination of plasma volume, an additional 0.2 ml bolus of saline containing 10 fLCi [1 4 C]inulin was given 3 min be fore decapitation. At the end of the experiment, a CSF sample was taken from the cisterna magna and a terminal plasma sample was obtained. Then the animal was decap itated and the brain was removed. Tissue samples were taken from the frontal cortex in all experiments except those with MCAo, where the cortex was sampled as de scribed previously herein.
Tissue samples were placed in a preweighed vial and weighed, then dissolved in 330 fLl of 1 M methylbenze thonium hydroxide at 60°C before addition of 6.5 ml of scintillation fluid. Whole blood samples were similarly incubated (20 min), then bleached with 50 fLl of 30% H202 before addition of scintillation fluid, whereas plasma sam ples were immediately diluted with methylbenzethonium hydroxide and scintillation fluid. CSF samples were treated as tissue samples. Dual label counting was per formed using a Beckman LS 3801 liquid scintillation spec trometer (Fullerton, CA, U.S.A.).
The permeabilities of eH]taurine and eH]-AIB at the BBB were assessed using a two-compartment model for blood to brain transfer (Ohno et aI., 1978) . This model assumes that tracer entry into brain is proportional to the plasma concentration of the tracer, that there is no ap preciable backflux within the period of tracer circulation, and that isotope exchange between CSF and brain extra cellular space is negligible. These conditions are accom plished for the present experiments by sampling only cor tex and by the shortness of tracer circulation (Smith and Rapoport, 1986) . Therefore, a rate constant for unidirec tional uptake (K I) relating the brain concentration of tracer over time to the arterial plasma concentration can be defined as:
( 1) where Cev(n is the terminal (time = n concentration of extravascular tracer in either the brain or CSF and fCadt is the integral of the arterial tracer concentration from time t = 0 to T. Cev(n was calculated from total tracer counts C,o,(n in the brain samples, final tracer plasma concen tration Cpl(n, and plasma volume PV as: 15, No.5, 1995 A similar two-compartmental model was employed to determine a K I for uptake into CSF. With CSF it is im possible to sample the whole of the CSF system. How ever, care was taken that a similar volume of CSF (l00 fLl) be taken from each rat. Thus, approximately the same portion of the CSF was sampled in each animal, facilitat ing comparisons between groups. The KI refers to the entry into that sample. A plasma volume correction was not necessary for CSF samples. Unidirectional fluxes of taurine (lin) from blood to brain and blood to CSF were calculated by mUltiplying the influx rate constant (K 1 ) by the plasma taurine concentration in each animal.
Tissue and plasma composition
Plasma [N a +] and [K +] were measured by flame pho tometry (lL 943 flame photometer, Instrumental Labora tories, Lexington, MA, U.S.A.), [Cl-] by coulometry (Digital chloridometer, Haake-Buchler Instruments, Sad dlebrook, NJ, U.S.A.), and osmolality by the vapor pres sure method (Wescor 5100 C vapor pressure osmometer, Logan, UT, U.S.A.). Tissue water content (g H20/g dry weight) was determined from sample wet and dry weights after desiccation for 24 h at 100°C.
For the measurement of tissue taurine, weighed sam ples were homogenized in 2 ml of ice-cold 0.05 M HCI0 4 at 20,000 rpm for 30 s (lKA T25-S1 homogenizer, Cincin nati, OH, U.S.A.) followed by centrifugation at O°C and 5,000 g for 10 min. Supernatant (20 fLl) was analyzed by HPLC using a 75 x 4.6-mm 3 fLm Beckman Ultrasphere chromatography column heated to 45°C and an isocratic elution profile after precolumn derivatization with 0phthalaldehyde. Amino acids were detected electrochemi cally (model 400 EC detector, Princeton Applied Re search). The mobile phase consisted of 80% 0.05 M NaH2P0 4 at pH 5.5 and 20% methylalcohol (Murai et aI., 1992) . Plasma taurine was determined by the same method after deproteinization with methanol. Tissue tau rine content was calculated relative to both tissue wet weight and dry weight. The latter value was obtained by dividing tissue taurine relative to tissue wet weight by tissue water content measured in separate animals. 
Materials
Statistical analysis
All data are reported as means ± standard deviation (SD). Statistical differences between ischemic and non ischemic cortices of the same animals were determined by the paired t test. Other statistical comparisons be tween the groups were by analysis of variance with posthoc Scheffe F test where necessary for comparisons of multiple groups. The rules of error propagation were applied for the calculation of tissue taurine contents rel ative to tissue dry weight from two independent experi ments, and for the calculation of the ischemic taurine loss, corrected for ischemic edema. Confidence intervals were calculated for these data to determine their statistical sig nificance. Regression analysis was performed where ap propriate. The 0: error probability for significant differ ences was set at p < 0.05 (two-tailed).
RESULTS
Taurine infusion
Physiological parameters measured in the taurine and vehicle infusion experiments are given in Table  1 . Taurine infusion increased plasma taurine four fold compared with vehicle-infused rats. All other physiological variables were not significantly differ ent between the two groups.
In the anterior cortex, the influx rate constant (K1 ) for eHltaurine was significantly reduced in taurine-infused compared with vehicle-infused rats (2.1 ± 0.5 and 7.3 ± 2.0 J.Ll/g/min, respectively; p < 0.001). However, a similar comparison of the K 1 for entry into the CSF (taurine infusion, 0.6 ± 0.1 J.LII glmin; vehicle infusion, 0.8 ± 0.3 J.Ll/gimin) was not significant (p > 0.18). Figure 2A plots the relation between plasma taurine concentration and the K 1 for the anterior cortex and CSF. For the anterior cortex, Kl decreased as plasma taurine increased, approaching the abscissa with high taurine levels. Such a relationship would be expected in the pres ence of saturable uptake with a low Michaelis Menten constant (KM). Conversely, no relationship was found at the blood-CSF barrier, where Kl re mained constant in the face of increasing plasma taurine, as would be expected of a diffusional pro cess or a transporter with a high KM.
Unidirectional taurine fluxes (lin) were calculated for all animals from Kl and plasma taurine measure ments. The lin for entry at the blood-brain barrier was not increased during taurine infusion, probably indicating carrier saturation (Fig. 2B) . However, the lin into CSF was not kept constant, being sig nificantly higher in taurine-infused rats (p < 0.001).
Osmotic stress
Osmotic stress induced profound changes in the plasma taurine concentration ( Table I) . Hypo-, iso-, and hyperosmotic groups, with osmolalities of 258 ± 7, 288 ± 7, and 346 ± 19 mOsmol/kg and corre sponding disturbances in plasma Na + and Cl-, had plasma taurine concentrations of 400 ± 186, 100 ± 33, and 47 ± 4 J.LM, respectively. All animals in these groups developed slight metabolic acidosis.
The measurements of Kl for eH]taurine obtained during osmotic stress had a similar pattern to that found with taurine infusion. In the anterior cortex, the taurine K 1 was reduced in hypoosmotic rats where plasma taurine was high and increased in re- sponse to hyperosmolality where plasma taurine was low (Fig. 3A) . The lin of taurine into brain, therefore, remained constant irrespective of osmo lality (Fig. 3B) . In contrast, the CSF Kl was unaf fected by changes in osmolality and, therefore, lin was increased in hypoosmotic rats where plasma taurine concentrations were increased.
MCAo
Plasma taurine, 86 ± 31 J.LM, after 4 h of M CAo, was similar to that of the control animals from the other two sets of experiments. Although the Kl for taurine in the contralateral cortex (6.1 ± 0.9 J.Ll/gl Values are means ± SO. N. D. , not determined. For the infusion experiments rats were given artificial plasma with or without 50 mM taurine at 10 fLlIloo glmin i. v. for 35 min. Blood was sampled at 30 min, immediately before administration of isotope. For osmotic stress experiments, blood was sampled 30 min after the onset of the stress just before the determination of the influx rate constant. In the MCA occlusion group, data are pooled from the four different experimental groups (see text) because there were no significant differences between the groups except plasma taurine, which was only determined in those rats (n = 12) used for brain taurine uptake or content measurements. a p < 0.01 versus control, bp < 0.05 versus control, 'p < 0.05 versus hypoosmotic rats.
min) was similar to that obtained in the other con trol animals, there was a very pronounced (82 ± 4%) reduction in the taurine K) to 1.1 ± 0.2 ,.d/g/min in the ischemic tissue ( Fig. 4 ; p < 0.001). Two possible causes for the reduction in the tau rine KI were examined. The swelling of the isch emic tissue through edema formation will decrease the BBB surface area per unit wet weight. Four hours of ischemia resulted in the water content of the ischemic tissue increasing to 4.32 ± 0.16 gig dry weight compared with 3.51 ± 0.05 gig dry weight in the contralateral hemisphere (Fig. 5 ). This edema formation decreased the dry weight per wet weight of brain by 15%. Assuming that capillary surface area varies with the dry weight fraction, this differ ence would not account for the measured change in taurine KI• In other animals the possibility that the change in taurine K I with ischemia might reflect a change in the surface area or passive permeability properties of the BBB was examined by measuring the KI for AlB. Four hours after MeAo there was no increase in the AlB KI, as might be expected if the BBB were disrupted; rather, the KI was decreased ( Fig. 4 ; p < 0.05). The decrease in the KI for AlB, 41 ± 32%, was less than the 82 ± 4% reduction found for tau rine (p < 0.05).
Mter 4 h, taurine content in the ischemic tissue was 4.8 ± 0.5 mmollkg wet weight, significantly less than in the contralateral tissue (7.4 ± 0.8 mmollkg; p < 0.001). Even if the tissue content is expressed per kilogram dry weight, there was significantly less taurine in the ischemic tissue (Fig. 5) . The differ ence between ischemic and contralateral hemi spheres was 7.4 ± 4.7 mmol/kg dry weight (95% Values are means ± SD, n = 6. lower confidence interval: 2.5 mmol/kg dry weight), corresponding to a 22% taurine loss. The rate of tau rine loss was calculated as 31 ± 20 nmol/g dry weight/ min or 6.8 ± 4.3 nmol/g wet weight/min (95% lower confidence interval: 2.3 nmol/g wet weight/min).
DISCUSSION
Taurine has been implicated in a variety of phys iological and pathophysiological processes and, therefore, an understanding of the mechanisms that control brain taurine is important. Because appre ciable taurine biosynthesis in the CNS seems to be lacking, brain tissue relies on taurine transported from blood across the BBB to meet its metabolic needs (Huxtable, 1989) . The results presented in this article suggest that the influx of taurine into the brain is via a specific transporter that maintains in flux constant during fluctuations in plasma taurine induced by taurine infusion or osmotic stress. How ever, during ischemia there may be a derangement of taurine influx.
Saturable uptake of taurine at the BBB
The present investigation provides evidence for saturable, i.e., carrier-mediated transfer of taurine from blood to brain across the BBB. While a diffu sion component of taurine across the BBB cannot be ruled out, its contribution to taurine uptake at physiological plasma levels of the amino acid is pre sumably small compared with the transport compo nent, as can be judged from the influx rate constants (K,) measured at high plasm� taurine levels. The data suggest that the K M for taurine influx (lin) at the BBB is substantially less than the normal tau rine concentration found in rat plasma, and it may be a high-affinity uptake system as found in cul tured neurons and astroeytes (Borg et aI., 1980; Larsson et al.; and isolated capillaries (Taya rani et aI., 1989) .
In contradistinction to the BBB, the CSF K, re mained unaffected by increasing plasma taurine concentrations, indicating the predominance of dif fusion or a low-affinity transporter for taurine movement across the choroid plexus epithelium, the blood-CSF barrier. Conceivably, radioactivity accumulating in CSF during the experiment could have been the result of diffusion or bulk flow from tissue. However, the period of tracer recirculation was too short to allow significant exchange (Smith and Rapoport, 1986) . Furthermore, if meaningful amounts of tracer had reached CSF from brain in terstitial fluid, the K, calculated for CSF would have been expected to follow the pattern estab lished for tissue, which was not the case.
The saturation of blood-brain barrier taurine transport may be important in guarding the brain from fluctuations in plasma taurine concentration. Lefauconnier et al. (1978) have shown that even very large increases in plasma taurine are not re flected in changes in brain taurine content. This ob servation is explained by the present data, because increases in plasma taurine would not be accompa nied by increases in lin '
Taurine transport during osmotic stress
From the results presented in this article, It IS unlikely that changes in taurine unidirectional influx are involved in the net loss of brain taurine that occurs during acute hypoosmotic stress (Verbalis and Gullands, 1991; Sterns et aI., 1993) . Such loss probably reflects increased efflux through nonsat urated abluminal transport systems after an in crease in the taurine concentration in the extracel-lular space (see later in this article). However, the kinetics of blood to brain taurine transport do serve to maintain the lin for taurine constant in the face of substantial changes in plasma taurine induced by osmotic stress. If the carrier were not saturated, the fourfold rise in plasma taurine that occurs during hypoosmotic stress would increase the rate of tau rine uptake, thereby decreasing the net loss of tau rine from the brain. Similarly, if the carrier were not saturated, the reduction in plasma taurine that oc curs in hyperosmotic stress would diminish influx and thereby limit the net uptake of taurine that oc curs in this condition to attenuate brain shrinkage (Tracht man et aI., 1988; Thurston et aI., 1983) .
The absence of any effect of hypoosmotic stress on lin suggests that brain swelling does not trigger regulators of this parameter. This makes it unlikely that the apparent decrease in taurine uptake found during ischemia is a regulatory event to limit edema formation.
Taurine transport during ischemia
In contrast to previous studies, which found little if any effect of ischemia or anoxia on the K 1 for another amino acid, leucine, at the BBB (Betz et aI., 1975; Sage et aI., 1984; Brust, 1991) , cerebral ischemia induced a very marked decline in this pa rameter for taurine. This reduction, -80%, could not be accounted for by tissue edema. Similarly, measurements of the Kl for AlB suggest that the reduction in taurine Kl cannot be accounted for by changes in the surface area of the capillary network because that would equally affect both AlB and tau rine. They also suggest that any reduction in the passive permeability of the BBB is not of a magni tude that would reduce taurine influx by this extent. The BBB permeability to taurine is also so low that it is unlikely that the rate of taurine uptake would be limited by the rate of blood flow to the ischemic tissue even in the core, where blood flow is reduced to 1{).-15% of control (Yang and Betz, 1994) .
One plausible explanation for the decrease in the Kl of taurine is that the concentration of unlabeled taurine increases in blood as it circulates through the brain, competing with the isotopic taurine for uptake. The ischemic tissue lost taurine at the rate of 7 nmol/g wet weight/min. Assuming that this is all lost to blood flowing at a rate of 100 fLl/g/min with a hematocrit of 40%, this would result in an increase from 86 to 203 fLM in the plasma taurine concentra tion during passage through the ischemic tissue. Be cause the taurine transporter appears saturated, such a doubling in concentration could greatly re duce the influx rate constant. As in osmotic stress, if this scenario occurs, the saturation of the taurine J Cereb Blood Flow Metab, Vol. 15, No.5, 1995 influx transporter serves to prevent taurine lost te the blood from being taken back up into the brain.
Another possible, and not mutually exclusive, cause for the decline in taurine K 1 may be an effect of ischemia on the endothelial Na gradient. Na gra dients drive taurine influx in many tissues (Hux table, 1989) , including the abluminal transporter in cerebral microvessels where external Na removal or addition of ouabain inhibits taurine uptake (Taya rani et aI., 1989) . If MCAo alters the Na gradient of the cerebral endothelial cells, as occurs in other brain tissues, it would result in a decreased rate of taurine uptake. Interestingly, the uptake of leucine into the brain, which is via a sodium-independent L-system, is not inhibited by anoxia (Betz et aI., 1975) . If the decrease in taurine uptake does reflect a change in endothelial cell Na gradient, this change precedes BBB disruption. Thus, potentially, BBB taurine transport could be used as an early marker for BBB dysfunction.
Role of taurine in cerebral ischemia
During 4 h of MCAo there is a net increase in the tissue contents of the major ions N a + , K + , and CI of -60 mmol/kg dry weight (unpublished data). The loss of taurine measured in this study, amounting to -7 mmollkg dry weight, will therefore suffice to reduce this osmole gain by -10% and may alleviate the evolution of tissue edema accompanying focal ischemia.
The loss of taurine could theoretically either re sult from enhanced taurine efflux or reduced influx, because appreciable metabolism of taurine in cere bral cells is lacking (Walz and Allen, 1987) . Even with the almost total abolishment of taurine uptake, the reduction in influx only amounts to -0.6 mmoll kg dry weight during 4 h. Thus, the major cause of the loss of taurine must be accelerated efflux. The increase in efflux was observed in the face of an intact BBB, as demonstrated by the passive perme ability marker eHl-AIB, suggesting that the efflux is carrier mediated. The observed increase in efflux, -7 mmol/kg dry weight/4 h is much greater than the capacity for blood to brain taurine transport. This observation is in accord with the finding of low brain extracellular space taurine concentrations, as measured at the CSF, of only 10 fLM (Semba and Patsalos, 1993) compared to 100 fLM in plasma. Tayarani et al. (1989) have estimated that the KM for Na-dependent taurine transport from brain to blood is -30 fLM and, thus, unlike the blood to brain transport, this system is probably not saturated un der normal physiological conditions. Such an efflux system would be stimulated during ischemia, when extracellular taurine concentration increases (Butcher et aI., 1990; Shimada et aI., 1993; Korf et aI., 1988) .
If, as suggested previously herein, the reduction in taurine influx during ischemia represents a reduc tion in the endothelial N a gradient that is linked to taurine transport, the dissipation of this gradient will also affect taurine efflux from the brain. Endo thelial cell dysfunction, therefore, may limit taurine extrusion from the brain and lessen a mechanism that would normally limit brain swelling.
